BIG PHARMA EARNINGS WATCH: AMGEN AND PFIZER
Amgen and Pfizer Bring in Billions of Revenue in Q2 Following Continued Price… Read More
© 2026 CSRXP- All Rights Reserved
THEY SAID IT! U.S. SENATE EXPERTS HIGHLIGHT BIPARTISAN, MARKET-BASED SOLUTIONS TO HOLD BIG PHARMA ACCOUNTABLE FOR PATENT ABUSE, BOOST COMPETITION TO LOWER DRUG PRICES
Joint DOJ-FTC Listening Session Focuses on Solutions to Foster Greater… Read More
DOSE OF REALITY: REPORT FINDS BIG PHARMA RIDER IN TAX LAW LIKELY TO COST SENIORS AND TAXPAYERS FAR MORE THAN PREVIOUSLY ESTIMATED
The Wall Street Journal Finds Pharma-Backed Provision Likely to Enable Big… Read More
BIG PHARMA EARNINGS WATCH: ABBVIE AND BRISTOL MYERS SQUIBB
AbbVie and Bristol Myers Squibb Report Better-Than-Expected Earnings in the… Read More
BIG PHARMA EARNINGS WATCH: ASTRAZENECA AND GSK
Pair of Big Pharma Giants Beat Expectations After Hiking Prices on Nearly 50… Read More
CSRxP ENCOURAGES HELP COMMITTEE TO HIGHLIGHT BIG PHARMA’S EGREGIOUS PRICING AND ANTI-COMPETITIVE PRACTICES IN HEARING ON HEALTH CARE AFFORDABILITY
Lawmakers Can Build on Track Record of Bipartisan Collaboration by Advancing… Read More
Second Opinion: Big Pharma’s Advertising Carries a Big Price Tag for American Patients and Taxpayers
Washington Post Editorial Misses Connection Between DTC Advertising and Higher… Read More
BIG PHARMA EARNINGS WATCH: ROCHE
Roche Continues Hiking Prices on Blockbuster Drugs While Beating Wall Street… Read More
BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON
Pharmaceutical Giant Beats Wall Street Expectations While Hiking Prices on… Read More
CSRxP STATEMENT ON U.S. SENATE REINTRODUCTION OF THE ETHIC ACT
Coalition Commends Bipartisan Group of Lawmakers for Commitment to Cracking… Read More
THEY SAID IT! CONSUMER ADVOCATES AND EXPERTS SHINE A LIGHT ON BIG PHARMA’S EGREGIOUS ANTI-COMPETITIVE TACTICS THAT EXTEND MONOPOLIES AND KEEP DRUG PRICES HIGH
FTC Listening Session Highlights How Big Pharma Undermines Competition from… Read More
CSRxP STATEMENT ON BIG PHARMA GIVEAWAY IN RECONCILIATION BILL TEXT
Pharma-Backed Policy Would Cost Seniors and Taxpayers Billions of Dollars in… Read More